Pharmaceutical giant Pfizer has been slapped with a $US141 million ($155 million) fine for unlawfully promoting an epilepsy drug for unapproved uses, reports law.com. A jury found the company guilty of breaching federal racketeering laws which promoted use of the drug Neurontin for conditions on which it did not work. The plaintiffs, Kaiser Foundation Hospitals and Health Plan, were tricked into believing the drug could successfully treat migraines and bipolar disorder.
Seventeen corporate lawyers from Simmons & Simmons' Rome office are jumping ship to DLA Piper, reports The Lawyer. The team, including four partners, will join an existing DLA Piper team in Rome consisting of 13 fee earners. The move will leave Simmons' Rome office, especially the corporate team, looking seriously diminished.
A group of Indian lawyers is calling for government action over allegations that 31 foreign firms and a legal process outsourcing company were illegally practicing law in India, reports legalweek.com. According to the group, lawyers from foreign firms were conducting business "out of five star hotels and business centres". Included in the list of accused - which has been filed in the Madras High Court by way of petition - are Allen & Overy, Clifford Chance, White & Case and Shearman & Sterling.
A British tax barrister has resigned from his position at Birmingham's St Philip's Chambers in order to contest a seat in the far right British National Party (BNP), reports The Lawyer. Robert Grierson, who attended the same university college as controversial BNP leader Nick Griffin, will contest the seat at the upcoming election.
The British Solicitors Regulation Authority (SRA) has undergone its "biggest ever consultation" as it attempts to dramatically rejuvenate the Solicitors' Code of Conduct, reports legalweek.com. According to the SRA, the rigorous shake-up is set to concentrate on the regulation of specific firms and conduct which pose the greatest danger to clients, and to establish much clearer ethical guidelines.
Like this story? Read more: